Trials / Recruiting
RecruitingNCT07168096
Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
NEOPSYCO STUDY: Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 540 (estimated)
- Sponsor
- Fundación Sociedad Española de Oncologia Médica · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To examine the trajectories of anxiety and depression symptoms over the course of oncological disease, and to assess potential predictors-sociodemographic (age, sex, marital status, employment status), clinical (tumor location, stage, treatment type, general health), psychological (coping strategies, quality of life, cognitive difficulties, fear of recurrence), and physical activity-and their association with support needs and utilization of psychosocial services.
Detailed description
The study population consists of consecutive oncology patients recruited across multiple centers, with data collection occurring at baseline (diagnosis or treatment initiation) and at 3-month and 6-month follow-up time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Psychosocial and clinical assessment | Participants complete standardized self-report questionnaires and undergo medical record review at three time points (baseline, 3 months, and 6 months) to assess psychological symptoms (anxiety, depression, somatization), coping strategies, quality of life, cognitive difficulties, physical activity, nutrition, supportive care needs, and informed decision-making in the context of cancer treatment. No experimental treatment or therapy is administered. |
Timeline
- Start date
- 2024-09-12
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-09-11
- Last updated
- 2025-09-11
Locations
18 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT07168096. Inclusion in this directory is not an endorsement.